Gene · 51548
Papers4,574
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 4,574
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Translocation of SIRT6 promotes glycolysis reprogramming to exacerbate diabetic angiopathy. | Redox Biol | 2025 | 40580755 | PubTator, text mining | PubMed |
| A comprehensive review of histone modifications during mammalian oogenesis and early embryo development. | Histochem Cell Biol | 2025 | 40580240 | PubTator, text mining | PubMed |
| Molecular Crosstalk Between SIRT1, Wnt/β-Catenin Signaling, and Inflammatory Pathways in Renal Transplant Rejection: Role of miRNAs, lncRNAs, IL-1, IL-6, and Tubulointerstitial Inflammation. | Medicina (Kaunas) | 2025 | 40572763 | PubTator, text mining | PubMed |
| Hederagenin promotes SIRT6 to attenuate epidural scar formation by aggravating PRMT1 deacetylation. | Bone Joint Res | 2025 | 40511498 | PubTator, text mining | PubMed |
| Pterostilbene: A natural compound for anti-ageing in sebaceous gland cells and fibroblasts. | Int J Cosmet Sci | 2025 | 40476376 | PubTator, text mining | PubMed |
Down-regulation of serum SIRT6 levels is associated with an increased risk of chronic intestinal inflammation in children exposed to airborne particulate matter and polycyclic aromatic hydrocarbons from e-waste. | Environ Int | 2025 | 40449062 | PubTator, text mining | PubMed |
| New Perspectives on Postmenopausal Osteoporosis: Mechanisms and Potential Therapeutic Strategies of Sirtuins and Oxidative Stress. | Antioxidants (Basel) | 2025 | 40427485 | PubTator, text mining | PubMed |
| The advances in acetylation modification in senescence and aging-related diseases. | Front Physiol | 2025 | 40421455 | PubTator, text mining | PubMed |
| Structural Insights Into centSIRT6: Bioinformatic Analysis of N308K and A313S Substitution Effects. | Bioinform Biol Insights | 2025 | 40416060 | PubTator, text mining | PubMed |
| Senkyunolide A mitigates lipid deposition in hyperlipidemic hepatocytes through SIRT6-mediated suppression of oxidative stress and fetuin-A. | Biochem Biophys Res Commun | 2025 | 40403679 | PubTator, text mining | PubMed |
| PKCδ Regulates DNA Damage and Cell Death through a SIRT6/Nrf2-dependent Antioxidant Response. | Mol Cancer Res | 2025 | 40358612 | PubTator, text mining | PubMed |
| Sirt6 deficiency exacerbates angiotensin II-induced lipid nephrotoxicity by affecting PLD6-derived cardiolipin metabolism in podocytes. | Cell Signal | 2025 | 40355014 | PubTator, text mining | PubMed |
| A review shows that ATG10 has been identified as a potential prognostic marker and therapeutic target for cancer patients based on real-world studies. | Front Oncol | 2025 | 40313244 | PubTator, text mining | PubMed |
| Valdecoxib Ameliorates Apoptosis and Ferroptosis in Tenocytes via the SIRT6/NRF2-Mediated Suppression of Oxidative Stress. | Arch Med Res | 2025 | 40311381 | PubTator, text mining | PubMed |
| DNA stimulates the deacetylase SIRT6 to mono-ADP-ribosylate proteins with histidine repeats. | J Biol Chem | 2025 | 40280420 | PubTator, text mining | PubMed |
| Data reconstruction from machine learning models via inverse estimation and Bayesian inference. | Sci Rep | 2025 | 40263495 | PubTator, text mining | PubMed |
| Friend or foe? The role of SIRT6 on macrophage polarized to M2 subtype in acute kidney injury to chronic kidney disease. | Ren Fail | 2025 | 40260529 | PubTator, text mining | PubMed |
| miR-338-3p Targets SIRT6 to Inhibit Liver Cancer Malignancy and Paclitaxel Resistance. | Drug Dev Res | 2025 | 40258128 | PubTator, text mining | PubMed |
| NUP62 alleviates senescence and promotes the stemness of human dental pulp stem cells via NSD2-dependent epigenetic reprogramming. | Int J Oral Sci | 2025 | 40246825 | PubTator, text mining | PubMed |
| SIRT3/6/7: promising therapeutic targets for pulmonary fibrosis. | Front Cell Dev Biol | 2025 | 40241794 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51548/papers?page=12